| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Loder RT | |
| P433 | issue | 232 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 210-216 | |
| P577 | publication date | 1988-07-01 | |
| P1433 | published in | Clinical Orthopaedics and Related Research | Q5133783 |
| P1476 | title | The influence of diabetes mellitus on the healing of closed fractures |
| Q33681399 | A radiographic and clinical comparison of reamer-irrigator-aspirator versus iliac crest bone graft in ankle arthrodesis |
| Q38148115 | A review on the article: role of common biochemical markers for the assessment of fracture union |
| Q91658186 | Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study |
| Q34437563 | Aerobic glycolysis in osteoblasts |
| Q89874723 | Age-related changes to macrophages are detrimental to fracture healing in mice |
| Q50725306 | Altered expression of SDF-1 and CXCR4 during fracture healing in diabetes mellitus. |
| Q50044306 | Altered expression of microRNA during fracture healing in diabetic rats |
| Q91704996 | Altered microRNA profile during fracture healing in rats with diabetes |
| Q27312663 | Application of VEGFA and FGF-9 enhances angiogenesis, osteogenesis and bone remodeling in type 2 diabetic long bone regeneration |
| Q41861424 | Bioburden after Staphylococcus aureus inoculation in type 1 diabetic rats undergoing internal fixation. |
| Q39137277 | Bone Cell Bioenergetics and Skeletal Energy Homeostasis |
| Q37976305 | Bone, sweet bone--osteoporotic fractures in diabetes mellitus. |
| Q36117590 | Characteristics of inflammation common to both diabetes and periodontitis: are predictive diagnosis and targeted preventive measures possible? |
| Q41782043 | Chemokine expression is upregulated in chondrocytes in diabetic fracture healing |
| Q33727997 | Delayed fracture healing and increased callus adiposity in a C57BL/6J murine model of obesity-associated type 2 diabetes mellitus |
| Q45036458 | Detection of Pentosidine Cross-Links in Cell-Secreted Decellularized Matrices Using Time Resolved Fluorescence Spectroscopy |
| Q51748839 | Development of Controlled Drug Delivery Systems for Bone Fracture-Targeted Therapeutic Delivery: A Review. |
| Q36407732 | Diabetes and Its Effect on Bone and Fracture Healing. |
| Q37698523 | Diabetes and bone health: latest evidence and clinical implications |
| Q37238865 | Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment. |
| Q42329931 | Diabetes mellitus alters the mechanical properties of the native tendon in an experimental rat model |
| Q37600798 | Diabetes mellitus impairs tendon-bone healing after rotator cuff repair |
| Q35029163 | Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity |
| Q42616646 | Effect of the blood HbA1c level on surgical treatment outcomes of diabetics with ankle fractures. |
| Q57045573 | FOXO1 Deletion Reverses the Effect of Diabetic-Induced Impaired Fracture Healing |
| Q37040795 | Factors affecting outcome after total knee arthroplasty in patients with diabetes mellitus |
| Q37980336 | Fracture healing under healthy and inflammatory conditions |
| Q87641669 | Gene expression changes in cancellous bone of type 2 diabetics: a biomolecular basis for diabetic bone disease |
| Q35759258 | Glycemic Control with Thiazolidinedione Is Associated with Fracture of T2DM Patients |
| Q33996284 | Glycemic control and implant stabilization in type 2 diabetes mellitus |
| Q37362094 | High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing |
| Q64254915 | High-fat and high-glucose microenvironment decreases Runx2 and TAZ expression and inhibits bone regeneration in the mouse |
| Q47216487 | Immunomodulatory ECM-like Microspheres for Accelerated Bone Regeneration in Diabetes Mellitus. |
| Q90419968 | Impact of Diabetes Mellitus on Bone Health |
| Q37789186 | Inflammation as death or life signal in diabetic fracture healing. |
| Q25257772 | Influences of obese (ob/ob) and diabetes (db/db) genotype mutations on lumber vertebral radiological and morphometric indices: skeletal deformation associated with dysregulated systemic glucometabolism |
| Q41550650 | Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2 |
| Q24629773 | Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition |
| Q47565714 | Insulinlike growth factor gene expression in human fracture callus |
| Q36281802 | Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues |
| Q36285052 | Is the expression of Transforming Growth Factor-Beta1 after fracture of long bones solely influenced by the healing process? |
| Q36930480 | Local Application of Isogenic Adipose-Derived Stem Cells Restores Bone Healing Capacity in a Type 2 Diabetes Model |
| Q33736279 | Loss of insulin receptor in osteoprogenitor cells impairs structural strength of bone. |
| Q44683819 | Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. |
| Q54911885 | Management of ankle fractures in the elderly. |
| Q35029178 | Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis |
| Q36364298 | Offloading treatment is linked to activation of proinflammatory cytokines and start of bone repair and remodeling in Charcot arthropathy patients |
| Q90218092 | Osteoclasts in bone regeneration under type 2 diabetes mellitus |
| Q35842743 | Osteogenic progenitors in bone marrow aspirates have clinical potential for tibial non-unions healing in diabetic patients |
| Q42028937 | Osteogenic protein-1 overcomes inhibition of fracture healing in the diabetic rat: a pilot study |
| Q37096266 | Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it |
| Q47667508 | Parathyroid hormone (1-34) promotes fracture healing in ovariectomized rats with type 2 diabetes mellitus |
| Q36563665 | Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database |
| Q35582983 | Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes |
| Q51741993 | Pulsed electromagnetic fields preserve bone architecture and mechanical properties and stimulate porous implant osseointegration by promoting bone anabolism in type 1 diabetic rabbits. |
| Q34759492 | Recent advances in the use of serological bone formation markers to monitor callus development and fracture healing |
| Q40388484 | Regeneration of bone using nanoplex delivery of FGF-2 and BMP-2 genes in diaphyseal long bone radial defects in a diabetic rabbit model |
| Q37470198 | Role of hypoxia-inducible factor-1alpha in angiogenic-osteogenic coupling |
| Q36513158 | Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus |
| Q36253807 | Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model |
| Q37549113 | Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus |
| Q37421336 | Severe muscle trauma triggers heightened and prolonged local musculoskeletal inflammation and impairs adjacent tibia fracture healing |
| Q38747438 | Survivorship of medial opening wedge high tibial osteotomy in the elderly: two to ten years of follow up. |
| Q28078743 | Sweet Bones: The Pathogenesis of Bone Alteration in Diabetes |
| Q42274273 | TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1. |
| Q36772511 | The BB Wistar Rat as a Diabetic Model for Fracture Healing |
| Q37182800 | The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing. |
| Q52836232 | The effects of diabetes medications on post-operative long bone fracture healing. |
| Q47401003 | Treatment of critical-sized bone defects: clinical and tissue engineering perspectives. |
Search more.